Trial Information

Summary: Dyslipidemia (Elevated Cholesterol)

Study Objective: The objective of this study is to evaluate and compare the effects of once daily fenofibric acid monotherapy and simvastatin monotherapy with fenofibric acid and simvastatin combination therapy on CHD lipid risk factors in a population of patients with mixed dyslipidemia.

To qualify: Male and Female > 18 years
Patients must have the following fasting lipid results following =12-hour fasting period before the Baseline Visit (measured at the Screening Visit[s]); Study involves 6 out patient visits at center.

• TG level = 150 mg/dL, and
• HDL-C < 40 mg/dL (males) and <50 mg/dL (females), and
• LDL-C = 130 mg/dL.

Eligible participants will receive:

• Physical Examination
• Laboratory Assessment
• EKG
• Compensation for time and travel

If you are interested or know of someone who may qualify,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:43 AM